Author Lauren Lau Published March 6, 2021 Word count 1,121 Health Insurers and Prior Authorization Like sands through the hourglass, so are the days of prior authorization Medical Utilization Management “This procedure will require prior authorization.” Words that no patient or healthcare provider wants to hear when they are ready to proceed with a doctor-approved… Read More »
Print this page April 8, 2020 – Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAFV600E mutation, as detected by an FDA-approved test, after prior… Read More »
Making progress on automating the prior authorization process is looming as one of the top healthcare information technology policy challenges in the next year. Facilitating the process of gaining health plans’ approval for medical treatment has grown to be one of the biggest frustrations for physicians in group practices, said Robert Tennant, director of health… Read More »